Looking forward10 May 2025 12:00
SOLVONIS THERAPEUTICS PLC
(Incorporated and registered in England and Wales with registered
number 10776788)
Proposed acquisition of Awakn Life Sciences Corp.,
proposed authority to issue up to 7,500,000,000 new Ordinary Shares
and
Notice of General Meeting
he 2,074,378,592 new Ordinary Shares to be issued to the
Awakn Shareholders on Admission in consideration for their
securities held in Awakn, pursuant to the terms of the
Arrangement Agreement